GlassScriptPhysician profile
Raffaele Marchigiani
NPI 1629207139
$18,202.82
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,914 · 2020: $13K · 2021: $344 · 2022: $99.21 · 2023: $109 · 2024: $1,707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $888 · Consulting Fee: $525 · Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $888.14 |
| Consulting Fee | $525.00 |
| Food and Beverage | $401.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,477.05 | 2019-2024 | |
| Medtronic, INC. | $1,354.79 | 2021-2024 | Signia |
| Astrazeneca Pharmaceuticals LP | $525.00 | 2024 | Imfinzi |
| Covidien LP | $347.95 | 2019-2020 | |
| Davol INC. | $265.72 | 2019-2022 | |
| Atricure, INC. | $84.04 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $63.01 | 2020 | |
| W. L. Gore & Associates, INC. | $60.63 | 2019 | |
| Olympus America INC. | $24.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raffaele Marchigiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.